Literature DB >> 16081919

Analysis of the comparative workflow and performance characteristics of the VITEK 2 and Phoenix systems.

U Eigner1, A Schmid, U Wild, D Bertsch, A-M Fahr.   

Abstract

The VITEK 2 (bioMérieux, Marcy L'Etoile, France) and the Phoenix systems (BD Diagnostic Systems, Sparks, Md.) are automated instruments for rapid organism identification and susceptibility testing. We evaluated the workflow, the time to result, and the performance of identification and susceptibility testing of both instruments. A total of 307 fresh clinical isolates were tested: 141 Enterobacteriaceae, 22 nonfermenters, 93 Staphylococcus spp., and 51 Enterococcus spp. Manipulation time was measured in batches, each with seven isolates, for a total of 39 batches. The mean (+/- standard deviation [SD]) manipulation time per batch was 20.9 +/- 1.8 min for Phoenix and 10.6 +/- 1.0 min for VITEK 2 (P < 0.001). Mean (+/-SD) time to result for all bacterial groups was 727 +/- 162 min for Phoenix and 506 +/- 120 min for VITEK 2 (P < 0.001). Concerning identification, Phoenix and VITEK 2 yielded the same results for nonfermenters (100%), staphylococci (97%), and enterococci (100%). For 140 Enterobacteriaceae strains evaluated, 135 (96%) were correctly identified by Phoenix and 137 (98%) by VITEK 2 (P = 0.72). The overall category agreement for all isolates was 97.0% for both instruments. The minor error rate, major error rate, and very major error rate for all bacterial isolates tested were 3.0, 0.3, and 0.6 and 2.8, 0.2, and 1.7 for Phoenix and VITEK 2, respectively (P values of 0.76, 0.75, and 0.09). The VITEK 2 system required less manual manipulation time and less time than the Phoenix system to yield results.

Mesh:

Year:  2005        PMID: 16081919      PMCID: PMC1233988          DOI: 10.1128/JCM.43.8.3829-3834.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Evaluation of an automated system for identification of Enterobacteriaceae and nonfermenting bacilli.

Authors:  M F Jossart; R J Courcol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-12       Impact factor: 3.267

2.  Performance of the VITEK2 system for identification and susceptibility testing of routine Enterobacteriaceae clinical isolates.

Authors:  M Pérez-Vázquez; A Oliver; B Sánchez del Saz; E Loza; F Baquero; R Cantón
Journal:  Int J Antimicrob Agents       Date:  2001-05       Impact factor: 5.283

3.  Evaluation of the BD Phoenix automated identification and susceptibility testing system in clinical microbiology laboratory practice.

Authors:  E Stefaniuk; A Baraniak; M Gniadkowski; W Hryniewicz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-07-18       Impact factor: 3.267

4.  Evaluation of the automated phoenix system for potential routine use in the clinical microbiology laboratory.

Authors:  J-L Donay; D Mathieu; P Fernandes; C Prégermain; P Bruel; A Wargnier; I Casin; F X Weill; P H Lagrange; J L Herrmann
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

5.  Evaluation of the VITEK 2 system for rapid identification of medically relevant gram-negative rods.

Authors:  G Funke; D Monnet; C deBernardis; A von Graevenitz; J Freney
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

6.  Improved antimicrobial interventions have benefits.

Authors:  J Barenfanger; M A Short; A A Groesch
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

7.  Two-center collaborative evaluation of the performance of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of Enterococcus spp. and Staphylococcus spp.

Authors:  Anne-Marie Fahr; Ulrich Eigner; Martina Armbrust; Alexandra Caganic; Giuseppe Dettori; Carlo Chezzi; Luca Bertoncini; Magda Benecchi; Maria Grazia Menozzi
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

8.  Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing.

Authors:  J Barenfanger; C Drake; G Kacich
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

9.  Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci.

Authors:  N van Den Braak; W Goessens; A van Belkum; H A Verbrugh; H P Endtz
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

10.  Clinical impact of rapid in vitro susceptibility testing and bacterial identification.

Authors:  G V Doern; R Vautour; M Gaudet; B Levy
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

View more
  23 in total

1.  A biosensor platform for rapid antimicrobial susceptibility testing directly from clinical samples.

Authors:  Kathleen E Mach; Ruchika Mohan; Ellen Jo Baron; Mei-Chiung Shih; Vincent Gau; Pak Kin Wong; Joseph C Liao
Journal:  J Urol       Date:  2010-11-12       Impact factor: 7.450

2.  Two-center collaborative evaluation of performance of the BD phoenix automated microbiology system for identification and antimicrobial susceptibility testing of gram-negative bacteria.

Authors:  Maria Grazia Menozzi; Ulrich Eigner; Silvia Covan; Sabina Rossi; Pietro Somenzi; Giuseppe Dettori; Carlo Chezzi; Anne-Marie Fahr
Journal:  J Clin Microbiol       Date:  2006-09-27       Impact factor: 5.948

3.  Accuracies of beta-lactam susceptibility test results for Pseudomonas aeruginosa with four automated systems (BD Phoenix, MicroScan WalkAway, Vitek, and Vitek 2).

Authors:  Stefan Juretschko; Vincent J Labombardi; Stephen A Lerner; Paul C Schreckenberger
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

4.  Performance of MicroScan WalkAway and Vitek 2 for detection of oxacillin resistance in a set of methicillin-resistant Staphylococcus aureus isolates with diverse genetic backgrounds.

Authors:  Martin Kaase; Barbara Baars; Susanne Friedrich; Florian Szabados; S G Gatermann
Journal:  J Clin Microbiol       Date:  2009-06-10       Impact factor: 5.948

5.  Colorimetric-plate method for rapid disk diffusion susceptibility testing of Escherichia coli.

Authors:  Sehnaz Sener; Ibrahim Cagatay Acuner; Yuksel Bek; Belma Durupinar
Journal:  J Clin Microbiol       Date:  2011-01-19       Impact factor: 5.948

6.  Comparison of BD Phoenix AP Workflow with Vitek 2.

Authors:  Alan D Junkins; Sophie S Arbefeville; Wanita J Howard; Sandra S Richter
Journal:  J Clin Microbiol       Date:  2010-03-10       Impact factor: 5.948

7.  Phoenix 100 versus Vitek 2 in the identification of gram-positive and gram-negative bacteria: a comprehensive meta-analysis.

Authors:  Kalliopi-Stavroula Chatzigeorgiou; Theodoros N Sergentanis; Sotirios Tsiodras; Stavros J Hamodrakas; Pantelis G Bagos
Journal:  J Clin Microbiol       Date:  2011-07-13       Impact factor: 5.948

8.  Bacterial nanoscale cultures for phenotypic multiplexed antibiotic susceptibility testing.

Authors:  Emilie Weibull; Haris Antypas; Peter Kjäll; Annelie Brauner; Helene Andersson-Svahn; Agneta Richter-Dahlfors
Journal:  J Clin Microbiol       Date:  2014-07-02       Impact factor: 5.948

Review 9.  New and developing diagnostic technologies for urinary tract infections.

Authors:  Michael Davenport; Kathleen E Mach; Linda M Dairiki Shortliffe; Niaz Banaei; Tza-Huei Wang; Joseph C Liao
Journal:  Nat Rev Urol       Date:  2017-03-01       Impact factor: 14.432

10.  Comparison of the MicroScan, VITEK 2, and Crystal GP with 16S rRNA sequencing and MicroSeq 500 v2.0 analysis for coagulase-negative Staphylococci.

Authors:  Miyoung Kim; Se Ran Heo; Soon Hee Choi; Hyelin Kwon; Jeong Su Park; Moon-Woo Seong; Do-Hoon Lee; Kyoung Un Park; Junghan Song; Eui-Chong Kim
Journal:  BMC Microbiol       Date:  2008-12-23       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.